CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration

N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ (Online) 2015-05, Vol.350 (may14 15), p.h1793-h1793
Hauptverfasser: Shamseer, Larissa, Sampson, Margaret, Bukutu, Cecilia, Schmid, Christopher H, Nikles, Jane, Tate, Robyn, Johnston, Bradley C, Zucker, Deborah, Shadish, William R, Kravitz, Richard, Guyatt, Gordon, Altman, Douglas G, Moher, David, Vohra, Sunita
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:N-of-1 trials are a useful tool for clinicians who want to determine the effectiveness of a treatment in a particular individual. The reporting of N-of-1 trials has been variable and incomplete, hindering their usefulness in clinical decision making and by future researchers. This document presents the CONSORT (Consolidated Standards of Reporting Trials) extension for N-of-1 trials (CENT 2015). CENT 2015 extends the CONSORT 2010 guidance to facilitate the preparation and appraisal of reports of an individual N-of-1 trial or a series of prospectively planned, multiple, crossover N-of-1 trials. CENT 2015 elaborates on 14 items of the CONSORT 2010 checklist, totalling 25 checklist items (44 sub-items), and recommends diagrams to help authors document the progress of one participant through a trial or more than one participant through a trial or series of trials, as applicable. Examples of good reporting and evidence based rationale for CENT 2015 checklist items are provided.
ISSN:0959-8138
1756-1833
1756-1833
DOI:10.1136/bmj.h1793